| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.2 | 8e-08 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-05 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.16 | 0.0005 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.002 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.002 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |